Sebastian Hofmann

Vice President, Managing Director & Country Head Germany

Therapeutic Areas

Drug	Indication	Phase
Grafalon® (ATLG)	Prophylaxis of acute rejection in organ transplantation; Hematology/Oncology (e.g., stem cell transplantation conditioning)	Approved